+44 1300 500008Clinical & Experimental Cardiology : Citations & Metrics Report
Articles published in Clinical & Experimental Cardiology have been cited by esteemed scholars and scientists all around the world. Clinical & Experimental Cardiology has got h-index 14, which means every article in Clinical & Experimental Cardiology has got 14 average citations.
Following are the list of articles that have cited the articles published in Clinical & Experimental Cardiology.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
56 | 111 | 60 | 56 | 72 | 27 | 53 | 76 | 88 | 61 | 73 | 136 | 96 | 61 | 13 |
Research, Review articles and Editorials |
6 | 9 | 6 | 24 | 42 | 20 | 39 | 53 | 59 | 39 | 52 | 99 | 75 | 38 | 9 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
44 | 102 | 54 | 32 | 30 | 7 | 14 | 23 | 29 | 22 | 21 | 37 | 21 | 23 | 4 |
Conference proceedings |
18 | 25 | 41 | 43 | 3 | 49 | 398 | 389 | 515 | 204 | 157 | 126 | 26 | 33 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
143 | 212 | 54 | 63 | 88 | 70 | 62 | 294 | 304 | 211 | 147 | 75 | 29 | 93 | 0 |
| Journal total citations count | 2980 |
| Journal impact factor | 1.05 |
| Journal 5 years impact factor | 1.27 |
| Journal cite score | 1.34 |
| Journal h-index | 14 |
| Journal h-index since 2019 | 9 |
Important citations (1711)
Demaitre j. profiling pharmacokinetic parameters of liposomal formulations optimized for nanotherapy purposes (doctoral dissertation, university of minho). |
|
vinet r, martínez jl, guzmán l. the therapeutic potential of products based on polyphenols from wine grapes in cardiovascular diseases. intherapeutic medicinal plants: from lab to the market 2015 nov 16 (pp. 331-342). crc press. |
|
mansur ap, roggerio a, goes mf, avakian sd, leal dp, maranhão rc, strunz cm. serum concentrations and gene expression of sirtuin 1 in healthy and slightly overweight subjects after caloric restriction or resveratrol supplementation: a randomized trial. international journal of cardiology. 2017 jan 15;227:788-94. |
|
develi-is s, ozen g, bekpinar s, topal g, unlucerci y, dogan bs, uysal m. resveratrol improves high-fructose-induced vascular dysfunction in rats. canadian journal of physiology and pharmacology. 2014 oct 15;92(12):1021-7. |
|
chalal m, delmas d, meunier p, latruffe n, vervandier-fasseur d. inhibition of cancer derived cell lines proliferation by synthesized hydroxylated stilbenes and new ferrocenyl-stilbene analogs. comparison with resveratrol. molecules. 2014 jun 11;19(6):7850-68. |
|
wang l, han y, shen y, yan zq, zhang p, yao qp, shen br, gao lz, qi yx, jiang zl. endothelial insulin-like growth factor-1 modulates proliferation and phenotype of smooth muscle cells induced by low shear stress. annals of biomedical engineering. 2014 apr 1;42(4):776-86. |
|
ji h, wu l, ma x, ma x, qin g. the effect of resveratrol on the expression of adipor1 in kidneys of diabetic nephropathy. molecular biology reports. 2014 apr 1;41(4):2151-9. |
|
mendelsohn ar, larrick jw. trade-offs between anti-aging dietary supplementation and exercise. rejuvenation research. 2013 oct 1;16(5):419-26. |
|
j chu a. antagonism by bioactive polyphenols against inflammation: a systematic view. inflammation & allergy-drug targets (formerly current drug targets-inflammation & allergy). 2014 feb 1;13(1):34-64. |
|
mccalley ae, kaja s, payne aj, koulen p. resveratrol and calcium signaling: molecular mechanisms and clinical relevance. molecules. 2014 jun 5;19(6):7327-40. |
|
ergin v, hariry re, karasu ç. carbonyl stress in aging process: role of vitamins and phytochemicals as redox regulators. aging and disease. 2013 oct;4(5):276. |
|
yang x, li x, ren j. from french paradox to cancer treatment: anti-cancer activities and mechanisms of resveratrol. anti-cancer agents in medicinal chemistry (formerly current medicinal chemistry-anti-cancer agents). 2014 jul 1;14(6):806-25. |
|
rege sd, kumar s, wilson dn, tamura l, geetha t, mathews st, huggins kw, broderick tl, babu jr. resveratrol protects the brain of obese mice from oxidative damage. oxidative medicine and cellular longevity. 2013 sep 15;2013. |
|
rege sd, geetha t, griffin gd, broderick tl, babu jr. neuroprotective effects of resveratrol in alzheimer disease pathology. frontiers in aging neuroscience. 2014 sep 11;6:218. |
|
Navab m, reddy st, meriwether d, fogelman si, fogelman am (2015) apoa-i mimetic peptides: a review of the present status. inapolipoprotein mimetics in the management of human disease 15-27. |
|
ΠετÏοποÏλου ΠΙ. study of anti-inflammatory functions of hdl in experimental mouse models (doctoral dissertation). |
|
Sharifov of, anantharamaiah gm, gupta h (2015) effects of apoa-i mimetic peptide l-4f in lps-mediated inflammation. inapolipoprotein mimetics in the management of human disease 63-88. |
|
Constantinou c, karavia ea, xepapadaki e, petropoulou pi, papakosta e, et al. (2016) advances in high-density lipoprotein physiology: surprises, overturns, and promises. american journal of physiology-endocrinology and metabolism 310: e1-4. |
|
Porcar-almela m, codoner-franch p, tuzon m, navarro-solera m, carrasco-luna j, et al. left ventricular diastolic function and cardiometabolic factors in obese normotensive children. nutrition, metabolism and cardiovascular diseases 25: 108-115. |
|
Gordts sc, singh n, muthuramu i, geest bd (2014) pleiotropic effects of hdl: towards new therapeutic areas for hdl-targeted interventions. current molecular medicine 14: 481-503. |
|